Health Policy and High-Tech Industrial Development

Health Policy and High-Tech Industrial Development

Learning from Innovation in the Health Industry

Edited by Marco R. Di Tommaso and Stuart O. Schweitzer

By weaving together the fields of health economics, industrial organisation and industrial development, this book describes the benefits of promoting a country’s health industry as a way of stimulating its high-technology industrial capacity. The authors illustrate that the development of a country’s health industry not only improves the country’s health status, but also promotes an industry with relatively stable, high-wage employment, creates the potential for exporting goods and services, and produces scientific spillovers that will favourably impact other high-technology industries.

Chapter 6: Intangible Assets in the European Health Industry: The Case of the Pharmaceutical Sector

Patrizio Bianchi and Sandrine Labory

Subjects: economics and finance, health policy and economics, industrial economics, social policy and sociology, health policy and economics

Extract

Patrizio Bianchi and Sandrine Labory 1 INTRODUCTION A report to the European Commission (Gambardella et al., 2000) argues that the European drug industry is losing competitiveness with the USA, although there are differences among EU countries. In particular, the EU is lagging behind in its ability to generate, organize and sustain innovative processes and appears less able to translate R&D into commercial success, partly owing to a strategy of reliance on external inputs such as licences from international companies, pricing policies or peculiarities of the public regulatory and health care systems, rather than a strategy of reliance on own R&D and innovation. The European market is more fragmented and less competitive (prices do not fall after patent expiry) than the US one, European firms having to rely more on their domestic market to sell their products than on the whole European one. Parallel to this, a report to the European Commission by the High Level Expert Group on the Intangible Economy (HLEG, 2000) argues that a key element of competitivity has become the exploitation of intangible investments such as R&D, proprietary know-how, employees’ skills, world networks and brands and especially the capacity to combine external and internal sources of knowledge. Buigues et al. (2000) stress that intangibles such as R&D, marketing, advertising software and training, are growing in importance and have transformed the sources of competitiveness, so much so that public policies should change. They claim that public policies should shift focus towards sustaining intangible...

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information